NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.88
+0.0171 (+1.98%)
At Close: May 09, 2024
Steven Cohen Homes in on Otonomy by Expanding Stake
05:15pm, Wednesday, 15'th Jul 2020
Guru ups bet in biotech focused on ear-related disorders Continue reading...
Cipla gets USFDA nod for rare genetic condition treatment drug
11:14am, Tuesday, 14'th Jul 2020
Cipla's Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire's Firazyr, the company said in a regulatory filing.
Did Hedge Funds Make The Right Call On Amarin Corporation plc (AMRN) ?
12:11am, Tuesday, 14'th Jul 2020
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filin
Stocks To Watch: Bank Earnings And SPAC Deals Blaze In
08:25am, Saturday, 11'th Jul 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
Here's Why Amarin Tumbled 67.7% in the First Half of 2020
06:14pm, Wednesday, 08'th Jul 2020
The pharma stock collapsed on the threat of generic competition for a drug that launched in December 2019, but the move may have been a bit of an overreaction.
Analysts Recommend Catching These 2 Falling Knives
04:51pm, Wednesday, 08'th Jul 2020
Their share prices are predicted to bounce back strongly Continue reading...
Nemaura Medical Submits PMA Application for sugarBEAT® to U.S. FDA
12:00am, Tuesday, 07'th Jul 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
05:39pm, Monday, 06'th Jul 2020
The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (USFDA) to treat COVID-19 patients.
Amarin Corporation plc (NASDAQ:AMRN): Is Breakeven Near?
04:42pm, Friday, 03'rd Jul 2020
Amarin Corporation plc's (NASDAQ:AMRN): Amarin Corporation plc, a pharmaceutical company, develops and commercializes...
AMGN Stock Jumped 8%, Amgen Beats Novartis in Patent Battle
02:19pm, Thursday, 02'nd Jul 2020
U.S.-based pharmaceutical giant Amgen wins Appeal Court ruling upholding the patent of its drug Enbrel, Amgen (AMGN) stock is up.
Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know
09:50pm, Wednesday, 01'st Jul 2020
In the latest trading session, Amarin (AMRN) closed at $7.03, marking a +1.59% move from the previous day.
Merck KGaA (OTCMKTS:MKGAF) vs. Amarin (OTCMKTS:AMRN) Head-To-Head Contrast
02:52am, Wednesday, 01'st Jul 2020
Amarin (NASDAQ:AMRN) and Merck KGaA (OTCMKTS:MKGAF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst rec
Implied Volatility Surging for Amarin (AMRN) Stock Options
12:39pm, Tuesday, 30'th Jun 2020
Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.
Implied Volatility Surging for Amarin (AMRN) Stock Options
12:00am, Tuesday, 30'th Jun 2020
Stocks Analysis by Zacks Investment Research covering: Amarin Corporation PLC. Read Zacks Investment Research's latest article on Investing.com
